financial instruments 100.85 (33.27) 100.72 (33.40) Shares of gain from investments in an associate and a joint venture 1.23 2.54 0.00 0.00 Gain from change in a joint venture proportion 0.00 (8.80) 0.00 0.00

change in a joint venture proportion - (8.80) - - Other income 22.44 6.77 25.14 6.77 Total income 961.23 (179.41) 959.77 (175.20) The Company would like to inform the reasons for change of revenues as

: Unit: Million Baht Revenue Structure Q2/2019 Q2/2018 Change General Patient Revenue 1,384.2 1,284.6 99.6 7.8% Social Security Scheme Revenue 752.8 633.3 119.5 18.9% Other Revenue 30.0 27.3 2.7 9.9% Total

Securities and Exchange Act B.E. 2535 (1992), the Securities and Exchange Commission hereby issues the following regulations: Clause 1. In this Notification, “investment advisory company” means a securities

a Derivatives Business Operator _________ Whereas Section 24 of the Derivatives Act B.E. 2546 (2003) and Clause 2 of the Notification of the Securities and Exchange Commission No. KorThor/Nor/Khor. 37

Operator _________ Whereas Section 24 of the Derivatives Act B.E. 2546 (2003) and Clause 2 of the Notification of the Securities and Exchange Commission No. KorThor/Nor/Khor. 37/2548 Re: Qualifications and

of an Executive of a Derivatives Business Operator _________ Whereas Section 24 of the Derivatives Act B.E. 2546 (2003) and Clause 2 of the Notification of the Securities and Exchange Commission No

Microsoft Word - set-E _BOD 4-2019_ mh.doc 1 Ref: CSO. 018/2019 Date: 21st August 2019 Subject: The approval of financial statements, the change of directors, the appointment of Chairman of the Audit

of useful lives with reference to the Health Study Report from an independent engineering expert and the repair and maintenance of buildings, machinery and equipment. This is considered the Change in

data, particularly those from outside the company. In addition, any forward looking statements are subject to change as market conditions and actual outcomes may differ from forecasts. BAM makes no